News
HZNP
116.30
0.00%
0.00
Weekly Report: what happened at HZNP last week (0226-0301)?
Weekly Report · 03/04 09:07
Weekly Report: what happened at HZNP last week (0219-0223)?
Weekly Report · 02/26 09:08
Weekly Report: what happened at HZNP last week (0212-0216)?
Weekly Report · 02/19 09:08
Weekly Report: what happened at HZNP last week (0205-0209)?
Weekly Report · 02/12 09:08
BUZZ-Zealand Pharma slips on read-across from Eli Lilly forecast
Zealand Pharma slips on read-across from Eli Lilly forecast. Shares of Zealand Pharma ZELA.CO are trading at 4.4% lower after falling as much as 7.7% this morning. Eli Lilly & Co forecast a 2024 profit above Wall Street estimates.
Reuters · 02/07 15:19
BUZZ-Amgen down after Leerink Partners downgrades stock on weight-loss drug concerns
Amgen shares fall 2% to $309.87 premarket. Leerink Partners downgrades stock to "Market Perform" from "Outperform" on weight-loss drug concerns. Company's lead injectable drug candidate, MariTide, faces uncertainty about mid-stage results.
Reuters · 02/07 13:30
Amgen quarterly profit rises 15% as Horizon deal boosts results
Amgen quarterly profit rises 15% as Horizon deal boosts results. Revenue for the quarter totaled $8.2 billion. Amgen's October acquisition of rare disease drugmaker Horizon Therapeutics. Excluding Horizon's medications, Amgen said year-over-year product sales grew 5%.
Reuters · 02/06 21:02
3 Growth Pharma Stocks to Guard Your Portfolio
Investors might consider quality pharma stocks Zoetis Inc. (ZTS), Bristol-Myers Squibb Company (BMY), and Teva Pharmaceutical Industries Limited (TEVA) to guard their portfolio. The pharma industry is experiencing significant growth fueled by rising demand for personalized medicines. The life science, healthcare and drug discovery sectors have seen significant growth and innovation in the U.S.
Barchart · 02/06 13:17
Weekly Report: what happened at HZNP last week (0129-0202)?
Weekly Report · 02/05 09:08
Weekly Report: what happened at HZNP last week (0122-0126)?
Weekly Report · 01/29 09:07
Weekly Report: what happened at HZNP last week (0115-0119)?
Weekly Report · 01/22 09:08
Weekly Report: what happened at HZNP last week (0108-0112)?
Weekly Report · 01/15 09:07
Weekly Report: what happened at HZNP last week (0101-0105)?
Weekly Report · 01/08 09:08
Weekly Report: what happened at HZNP last week (1225-1229)?
Weekly Report · 01/01 09:07
Weekly Report: what happened at HZNP last week (1218-1222)?
Weekly Report · 12/25/2023 09:08
Weekly Report: what happened at HZNP last week (1211-1215)?
Weekly Report · 12/18/2023 09:08
Weekly Report: what happened at HZNP last week (1204-1208)?
Weekly Report · 12/11/2023 09:09
Weekly Report: what happened at HZNP last week (1127-1201)?
Weekly Report · 12/04/2023 09:08
Weekly Report: what happened at HZNP last week (1120-1124)?
Weekly Report · 11/27/2023 09:07
Weekly Report: what happened at HZNP last week (1113-1117)?
Weekly Report · 11/20/2023 09:08
More
Webull provides a variety of real-time HZNP stock news. You can receive the latest news about Horizon Therapeutics Pub L through multiple platforms. This information may help you make smarter investment decisions.
About HZNP
Horizon Therapeutics plc is an Ireland-based global biotechnology company. The Company is focused on the discovery, development and commercialization of medicines that address the critical needs of people impacted by rare, autoimmune and severe inflammatory diseases. The Company’s portfolio of medicines include ACTIMMUNE, BUPHENYL (sodium phenylbutyrate), PROCYSBI (cysteamine bitartrate), Prescription RAVICTI (glycerol phenylbutyrate), and other. ACTIMMUNE is part of a drug regimen used to treat Chronic Granulomatous Disease (CGD). BUPHENYL (sodium phenylbutyrate) is a tablet for oral administration and BUPHENYL (sodium phenylbutyrate) Powder for oral, nasogastric, or gastrostomy tube administration contains sodium phenylbutyrate. PROCYSBI (cysteamine bitartrate) delayed-release capsules and delayed-release oral granules is a prescription medicine used to treat nephropathic cystinosis in adults and children 1 year of age and older.